APA (7th ed.) Citation

Daunov, M., Alagha, I., Rashidi, A., Chaekal, O., van Besien, K., Kapp, M. E., & Ignatz-Hoover, J. J. (2026). Serological pseudoprogression of multiple myeloma after treatment with teclistamab. Leukemia & Lymphoma, 67(5), 1160. https://doi.org/10.1080/10428194.2025.2595221

Chicago Style (17th ed.) Citation

Daunov, Michael, Ibrahim Alagha, Arash Rashidi, Ok-Kyong Chaekal, Koen van Besien, Meghan E. Kapp, and James J. Ignatz-Hoover. "Serological Pseudoprogression of Multiple Myeloma After Treatment with Teclistamab." Leukemia & Lymphoma 67, no. 5 (2026): 1160. https://doi.org/10.1080/10428194.2025.2595221.

MLA (9th ed.) Citation

Daunov, Michael, et al. "Serological Pseudoprogression of Multiple Myeloma After Treatment with Teclistamab." Leukemia & Lymphoma, vol. 67, no. 5, 2026, p. 1160, https://doi.org/10.1080/10428194.2025.2595221.